Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population

C S Murray, S D Pipis, E C McArdle, L A Lowe, A Custovic, A Woodcock, National Asthma Campaign-Manchester Asthma and Allergy Study Group, C S Murray, S D Pipis, E C McArdle, L A Lowe, A Custovic, A Woodcock, National Asthma Campaign-Manchester Asthma and Allergy Study Group

Abstract

Background: Abnormal premorbid lung function is a risk factor for subsequent wheezing in children with one or no atopic parent. This study was undertaken to establish whether early lung function in high risk infants (both parents atopic) was a risk factor for respiratory symptoms in infancy and to examine the influence of maternal asthma, smoking, and allergen exposure during pregnancy on any association.

Methods: Infants were recruited from the NAC Manchester Asthma and Allergy Study cohort at birth. Partial forced expiratory flow volume technique under sedation was carried out to determine maximal flow at FRC (V'maxFRC). Children were followed prospectively and parents completed a standard respiratory questionnaire at one year of age.

Results: Sixty nine term infants (34 boys; 88% mothers non-smokers; no household pets) underwent respiratory function testing. Size adjusted V'maxFRC was significantly lower in infants who had recurrent wheeze during the first year of life (mean 1.3 ml/s/cm, 95% CI 0.99 to 1.60) than in those who did not (mean 2.03 ml/s/cm, 95% CI 1.71 to 2.36; p=0.01). V'maxFRC was also significantly lower in infants who had recurrent cough symptoms. In multivariate regression analysis, when adjusted for age at test, sex, maternal asthma, smoking and maternal mattress Der 1 levels, a lower size adjusted V'maxFRC score remained strongly associated with wheezing (OR 0.37, 95% CI 0.18 to 0.77, p=0.007). Maternal smoking also remained an independent risk factor (OR 29.85, 95% CI 2.46 to 362.5, p=0.008).

Conclusion: Significantly diminished lung function was present in high risk infants who subsequently wheezed and coughed. This was independent of maternal exposure to mite allergen, asthma, and smoking during pregnancy.

References

    1. Eur Respir J. 2000 Jan;15(1):151-7
    1. Am J Respir Crit Care Med. 1995 May;151(5):1434-40
    1. Lancet. 2001 Jul 21;358(9277):188-93
    1. Pediatr Res. 1977 Mar;11(3 Pt 2):210-5
    1. Am Rev Respir Dis. 1978 Jul;118(1):7-15
    1. J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):270-5
    1. J Appl Physiol Respir Environ Exerc Physiol. 1982 Nov;53(5):1220-7
    1. N Engl J Med. 1988 Oct 27;319(17):1112-7
    1. J Immunol Methods. 1989 Mar 31;118(2):227-35
    1. J Pharm Pharmacol. 1990 Jun;42(6):450-2
    1. Am Rev Respir Dis. 1991 Feb;143(2):312-6
    1. N Engl J Med. 1991 Apr 25;324(17):1168-73
    1. Am Rev Respir Dis. 1991 Nov;144(5):1012-5
    1. Am Rev Respir Dis. 1992 May;145(5):1129-35
    1. Arch Dis Child. 1992 Dec;67(12):1454-8
    1. Am Rev Respir Dis. 1993 Apr;147(4):811-7
    1. Am J Respir Crit Care Med. 1995 Sep;152(3):977-83
    1. Eur Respir J. 1997 Aug;10(8):1774-9
    1. Am J Respir Crit Care Med. 1998 Sep;158(3):700-5
    1. Am J Respir Crit Care Med. 1999 Feb;159(2):403-10
    1. Arch Dis Child. 2000 Apr;82(4):327-32

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe